Zimmer Biomet’s (ZBH) “Hold” Rating Reiterated at Truist Financial

Truist Financial reiterated their hold rating on shares of Zimmer Biomet (NYSE:ZBH – Free Report) in a research note published on Monday morning,Benzinga reports. Truist Financial currently has a $113.00 target price on the medical equipment provider’s stock, down from their prior target price of $118.00. Several other equities analysts also recently commented on ZBH. […]